Truist Securities Upgrades Amgen to Buy, Announces $320 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Robyn Karnauskas has upgraded Amgen (NASDAQ:AMGN) from Hold to Buy and set a price target of $320.
November 02, 2023 | 11:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen has been upgraded from Hold to Buy by Truist Securities, with a new price target of $320.
The upgrade from Hold to Buy by Truist Securities indicates a positive outlook for Amgen. The new price target of $320, if achieved, would represent a significant increase in the stock's value. This news is likely to have a positive impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100